Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Westerweel, Peter E ^a,b   Teraa, Martin ^a   Rafii, Shahin ^b   Jaspers, Janneke E ^a   White, Ian A ^b   Hooper, Andrea T ^b   Doevendans, Pieter A ^a   Verhaar, Marianne C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; LINBIT; STEM CELL FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DEPRESSION; CELL INTERACTION; COCULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG PELLET; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; STEM CELL MOBILIZATION; STREPTOZOCIN DIABETES;

ANIMALS; ANTIGENS, CD34; BONE MARROW; CELL COUNT; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; FLUOROURACIL; HEMATOPOIETIC STEM CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; MICE; MICE, INBRED C57BL; STEM CELLS;

MUS;

EID: 84875503747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060357     Document Type: Article

References (56)

1. Booth GL, Kapral MK, Fung K, Tu JV, (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368: 29-36.
2. Fadini GP, Avogaro A, (2012) It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications. Exp Diabetes Res 2012: 742976.
3. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, et al. (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99: 2239-2242.
4. Sheetz MJ, King GL, (2002) Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288: 2579-2588.
5. Waltenberger J, (2001) Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49: 554-560.
6. Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I, et al. (2006) Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49: 3075-3084.
7. Verhaar MC, Rabelink TJ, (1998) Endothelial function: strategies for early intervention. Cardiovasc Drugs Ther 12Suppl 1: 125-134.
8. Urbich C, Dimmeler S, (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353.
9. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, et al. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
10. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, et al. (2001) Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052.
11. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, et al. (2005) Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39: 733-742.
12. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, et al. (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972.
13. Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, et al. (2005) Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25: 296-301.
14. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, et al. (2005) Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 19: 2005-2007.
15. Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, et al. (2004) Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109: 2454-2461.
16. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, et al. (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124: 407-421.
17. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS, (2008) Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452: 442-447.
18. Kopp HG, Avecilla ST, Hooper AT, Rafii S, (2005) The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 20: 349-356.
19. Li Z, Li L, (2006) Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci 31: 589-595.
20. Yin T, Li L, (2006) The stem cell niches in bone. J Clin Invest 116: 1195-1201.
21. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, et al. (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376.
22. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, et al. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195-199.
23. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, et al. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786.
24. Fadini GP, Albiero M, Vigili de Kreutzenberg S, Boscaro E, Cappellari R, et al. (2012) Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans. Diabetes Care: Epub ahead of print.
25. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, et al. (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987.
26. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007.
27. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.
28. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, et al. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117: 1249-1259.
29. Kang L, Chen Q, Wang L, Gao L, Meng K, et al. (2009) Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clin Exp Pharmacol Physiol 36: e47-e56.
30. Ferraro F, Lymperi S, Mendez-Ferrer S, Saez B, Spencer JA, et al. (2011) Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 3: 104ra101.
31. Busik JV, Tikhonenko M, Bhatwadekar A, Opreanu M, Yakubova N, et al. (2009) Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med 206: 2897-2906.
32. Westerweel PE, van Velthoven CT, Nguyen TQ, den Ouden K, de Kleijn DP, et al. (2010) Modulation of TGF-beta/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model. Cardiovasc Diabetol 9: 55.
33. Stokman G, Leemans JC, Stroo I, Hoedemaeker I, Claessen N, et al. (2008) Enhanced mobilization of bone marrow cells does not ameliorate renal fibrosis. Nephrol Dial Transplant 23: 483-491.
34. Rafii S, Shapiro F, Rimarachin J, Nachman RL, Ferris B, et al. (1994) Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 84: 10-19.
35. Seandel M, Butler JM, Kobayashi H, Hooper AT, White IA, et al. (2008) Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proc Natl Acad Sci U S A 105: 19288-19293.
36. Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, et al. (2009) Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4: 263-274.
37. Tepper OM, Carr J, Allen RJ Jr, Chang CC, Lin CD, et al. (2010) Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair. Diabetes 59: 1974-1983.
38. Hazra S, Jarajapu YP, Stepps V, Caballero S, Thinschmidt JS, et al. (2013) Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia 56: 644-653.
39. Orlandi A, Chavakis E, Seeger F, Tjwa M, Zeiher AM, et al. (2010) Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 105: 703-712.
40. Leone AM, Rutella S, Bonanno G, Contemi AM, de Ritis DG, et al. (2006) Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol 111: 202-208.
41. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM, (1991) The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78: 961-966.
42. Voo S, Dunaeva M, Eggermann J, Stadler N, Waltenberger J, (2009) Diabetes mellitus impairs CD133(+) progenitor cell function after myocardial infarction. J Intern Med 265: 238-249.
43. Oikawa A, Siragusa M, Quaini F, Mangialardi G, Katare RG, et al. (2010) Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol 30: 498-508.
44. Dimmeler S, (2010) Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance. Arterioscler Thromb Vasc Biol 30: 1088-1093.
45. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
46. Heissig B, Werb Z, Rafii S, Hattori K, (2003) Role of c-kit/Kit ligand signaling in regulating vasculogenesis. Thromb Haemost 90: 570-576.
47. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, et al. (2007) Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56: 666-674.
48. Fadini GP, Albiero M, Seeger F, Poncina N, Menegazzo L, et al. (2013) Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. Basic Res Cardiol 108: 313.
49. Li HW, Sykes M, (2012) Emerging concepts in haematopoietic cell transplantation. Nat Rev Immunol 12: 403-416.
50. Ptaszek LM, Mansour M, Ruskin JN, Chien KR, (2012) Towards regenerative therapy for cardiac disease. Lancet 379: 933-942.
51. Carral A, de la Rubia J, Martin G, Martinez J, Sanz G, et al. (2002) Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies. Bone Marrow Transplant 29: 825-832.
52. Onodera R, Teramukai S, Tanaka S, Kojima S, Horie T, et al. (2011) Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis. Bone Marrow Transplant 46: 278-284.
53. Weisel KC, Moore MA, Kanz L, Mohle R, (2009) Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support. Stem Cells Dev 18: 229-234.
54. Wang X, Hisha H, Mizokami T, Cui W, Cui Y, et al. (2010) Mouse mesenchymal stem cells can support human hematopoiesis both in vitro and in vivo: the crucial role of neural cell adhesion molecule. Haematologica 95: 884-891.
55. Michejda M, (2004) Which stem cells should be used for transplantation? Fetal Diagn Ther 19: 2-8.
56. Wu AG, Michejda M, Mazumder A, Meehan KR, Menendez FA, et al. (1999) Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow, adult bone marrow, peripheral blood, and cord blood. Pediatr Res 46: 163-169.